Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NF-kB p65 ELISA Kit (AC2585)
Cat.#: ASET-1174
Specifications
Description Human NF-kB p65 ELISA Kit allows for the in vitro quantitative determination of human NF-kB p65 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1855 Rat Axin 2 ELISA Kit (AC3266) Quantitative inquiry ASET-1673 Mouse NKCC1 ELISA Kit (AC3084) Quantitative inquiry ASET-1007 Human MT3 ELISA Kit (AC2418) Quantitative inquiry ASET-1871 Mouse Synaptotagmin 1 ELISA Kit (AC3282) Quantitative inquiry ASET-1157 Canine Syndecan-1 ELISA Kit (AC2568) Quantitative inquiry ASET-2380 Human PEDF ELISA Kit (AC3791) Quantitative inquiry ASET-1723 Rat beta nerve growth factor ELISA Kit (AC3134) Quantitative inquiry ASET-1266 Mouse Cathepsin D ELISA Kit (AC2677) Quantitative inquiry ASET-1897 Mouse Estrogen Receptor beta ELISA Kit (AC3308) Quantitative inquiry ASET-1622 Human ASRGL1 ELISA Kit (AC3033) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket